Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01118208 · ClinicalTrials.gov registry record · NA
Blister Packaging Medication to Increase Treatment Adherence and Clinical Response
A NA study, sponsored by VA Eastern Colorado Health Care System.
- Completed
- Registry status
- NA
- Development phase
- 303
- Enrollment target
NCT01118208 is a NA study that has completed, run by VA Eastern Colorado Health Care System. The registered enrollment target is 303 participants.
The verdict
NCT01118208, a NA study, has completed, sponsored by VA Eastern Colorado Health Care System.
- COMPLETED
- Registry status
- NA
- Development phase
- 303 participants
- Enrollment target
Study Summary
This quantitative, interview-based study will determine if increased prescription medication adherence via blister pack administration will reduce suicide related behavior among the high risk population of patients discharged from a psychiatric inpatient unit. The aims of the project are to determine whether blister packaging medication significantly increases treatment adherence and if blister packaging significantly decreases intentional self-poisoning behavior (i.e., suicide attempts and completions). By tracking former psychiatric inpatients for 12 months post-discharge and obtaining monthly medication adherence ratings, we will determine if blister packaging (BP) medications leads to better adherence than dispensing as usual (DUA). The psychiatric patients we will be recruiting have been diagnosed with, major affective disorder, bipolar affective disorder, post-traumatic stress disorder, or schizophrenia (or any combination of these diagnoses). By tracking former psychiatric patients for 12 months post-discharge and obtaining monthly reports (self-report and medical record review) of suicide-related behaviors, we will determine if patients in the BP condition have less intentional self-poisoning behavior than those in the DAU condition.
Interventions
- OTHER Blister packaging medications
- OTHER Dispense as usual
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 303 participants |
| Start Date | 2009-09 |
| Est. Completion | 2014-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01118208
The ClinicalTrials.gov registry entry for NCT01118208 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 303 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Eastern Colorado Health Care System, which has 42 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Blister packaging medications is the first listed.
NCT01118208 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01118208 about?
NCT01118208 is a clinical study titled "Blister Packaging Medication to Increase Treatment Adherence and Clinical Response". This quantitative, interview-based study will determine if increased prescription medication adherence via blister pack administration will reduce suicide related behavior among the high risk population of patients discharged from a psychiatric inpatient unit. The aims of the project are to determin...
What is the current status of trial NCT01118208?
This trial is currently completed. It is a NA study. The enrollment target is 303 participants. The study started on 2009-09. Estimated completion is 2014-09.
What interventions are being tested in trial NCT01118208?
The interventions under investigation include: Blister packaging medications (OTHER), Dispense as usual (OTHER).
Who is sponsoring clinical trial NCT01118208?
This trial is sponsored by VA Eastern Colorado Health Care System, which has 42 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.